Fewer irAEs, or Simply Fewer Steroids? Rethinking Comparative Safety in HCC Immunotherapy
Journal of Gastroenterology and Hepatology · 2026-11 · 41 (11) · 3661-3662
DOI: 10.1111/jgh.70753 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 01.10.2026. Verfasst von Fang Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Hematology, Xianju People's Hospital, Zhejiang Southeast Campus of Zhejiang Provincial People's Hospital, Affiliated Xianj…. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Oncology and Hematology, Xianju People's Hospital, Zhejiang Southeast Campus of Zhejiang Provincial People's Hospital, Affiliated Xianju's Hospital, Hangzhou Medical College, Taizhou, Zhejiang, China.
ORCID-Profile: Fang Wang
Zitieren
APA
Wang, F., & Wang, M. (2026). Fewer irAEs, or Simply Fewer Steroids? Rethinking Comparative Safety in HCC Immunotherapy. Journal of Gastroenterology and Hepatology, 41(11), 3661-3662. https://doi.org/10.1111/jgh.70753
Vancouver
Wang F, Wang M. Fewer irAEs, or Simply Fewer Steroids? Rethinking Comparative Safety in HCC Immunotherapy. Journal of Gastroenterology and Hepatology. 2026;41(11):3661-3662. doi:10.1111/jgh.70753
BibTeX
@article{Wang2026,
author = {Wang, Fang and Wang, Minwu},
title = {Fewer irAEs, or Simply Fewer Steroids? Rethinking Comparative Safety in HCC Immunotherapy},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
volume = {41},
number = {11},
pages = {3661--3662},
doi = {10.1111/jgh.70753}
}
EUVIMED